Atlas Trials

ITI-007 (Lumateperone Tosylate) for Schizophrenia

Clinical trial NCT03817528 · TERMINATED

Trial details

NCT number
NCT03817528
Sponsor
New York State Psychiatric Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2019-03-01
Primary completion
2020-09-23
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.